NCT07449260

Brief Summary

TSH has been suggested to be involved in reproductive challenges such as ovulatory issues, infertility, miscarriage, and maternal complications for many years. Multiple studies have associated thyroid function with ovarian function and reproductive physiology. The thyroid hormone can impact follicle development, as well as the metabolism of estrogen and androgen, the menstrual cycle, and the receptivity of the endometrium

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2019

Completed
5.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2025

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

February 27, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 4, 2026

Completed
Last Updated

March 10, 2026

Status Verified

March 1, 2026

Enrollment Period

5.9 years

First QC Date

February 27, 2026

Last Update Submit

March 6, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • ICSI outcome and its relation with TSH level

    Number of oocyte retrieved , percentage of fertilization rate, cleavage rate, available embryo rate, pregnancy rate analyzed to explore whether serum TSH level in miu/L affect ourtcome or not .

    4years

Study Arms (2)

Group A

Patients with TSH\<2.5 miu/L

Other: Basal TSH level

Group B

Patients with TSH 2.5-4 miu/L

Other: Basal TSH level

Interventions

On day 2-3 of spontaneous cycles, all planned women for ICSI cycle had basal TSH level measurment

Group AGroup B

Eligibility Criteria

Age20 Years - 35 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Infertile women attended at El Kasr Al Ainy IVF unit

You may qualify if:

  • Body mass index (BMI): women with BMI 18 : 30 kg/m2.
  • Favorable (average) responders to IVF stimulation: Anti-mullirian hormone (AMH) level \>1.0 ng/mL but \<3.5 ng/mL and antral follicular count (AFC) 5-10.
  • The embryos were transferred freshly or frozen .
  • Medically free

You may not qualify if:

  • Women with polycystic ovary syndrome (PCOS).
  • Poor ovarian response.
  • Severe teratoathenospermia.
  • women with chronic disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shaimaa El Shemy

Giza, Cairo Governorate, 4240310, Egypt

Location

MeSH Terms

Conditions

Infertility, Female

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesInfertility

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor of Obstetrics and Gynecology

Study Record Dates

First Submitted

February 27, 2026

First Posted

March 4, 2026

Study Start

January 1, 2019

Primary Completion

December 1, 2024

Study Completion

February 1, 2025

Last Updated

March 10, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

Locations